Jan 19 (Reuters) - Orexigen Therapeutics Inc:
* OREXIGEN THERAPEUTICS SAYS ‍EXPECT ANNUALIZED SAVINGS ASSOCIATED WITH FEB 2018 REDUCTION IN SALES FORCE OF ABOUT $30 MILLION​ - SEC FILING Source text: ( bit.ly/2Bg6XUc ) Further company coverage:
 